Close Menu
TechCentralTechCentral

    Subscribe to the newsletter

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    Facebook X (Twitter) YouTube LinkedIn
    WhatsApp Facebook X (Twitter) LinkedIn YouTube
    TechCentralTechCentral
    • News

      Nissan doubles down on South Africa despite plant uncertainty

      11 July 2025

      MultiChoice is working on a wholesale overhaul of DStv

      10 July 2025

      Spam call epidemic: operators say their hands are tied

      10 July 2025

      Britehouse unit breaks free from NTT Data

      10 July 2025

      Samsung’s bet on folding phones faces major test

      10 July 2025
    • World

      Grok 4 arrives with bold claims and fresh controversy

      10 July 2025

      Bitcoin pushes higher into record territory

      10 July 2025

      Cupertino vs Brussels: Apple challenges Big Tech crackdown

      7 July 2025

      Grammarly acquires e-mail start-up Superhuman

      1 July 2025

      Apple considers ditching its own AI in Siri overhaul

      1 July 2025
    • In-depth

      Siemens is battling Big Tech for AI supremacy in factories

      24 June 2025

      The algorithm will sing now: why musicians should be worried about AI

      20 June 2025

      Meta bets $72-billion on AI – and investors love it

      17 June 2025

      MultiChoice may unbundle SuperSport from DStv

      12 June 2025

      Grok promised bias-free chat. Then came the edits

      2 June 2025
    • TCS

      TCS | Connecting Saffas – Renier Lombard on The Lekker Network

      7 July 2025

      TechCentral Nexus S0E4: Takealot’s big Post Office jobs plan

      4 July 2025

      TCS | Tech, townships and tenacity: Spar’s plan to win with Spar2U

      3 July 2025

      TCS+ | First Distribution on the latest and greatest cloud technologies

      27 June 2025

      TCS+ | First Distribution on data governance in hybrid cloud environments

      27 June 2025
    • Opinion

      In defence of equity alternatives for BEE

      30 June 2025

      E-commerce in ICT distribution: enabler or disruptor?

      30 June 2025

      South Africa pioneered drone laws a decade ago – now it must catch up

      17 June 2025

      AI and the future of ICT distribution

      16 June 2025

      Singapore soared – why can’t we? Lessons South Africa refuses to learn

      13 June 2025
    • Company Hubs
      • Africa Data Centres
      • AfriGIS
      • Altron Digital Business
      • Altron Document Solutions
      • Altron Group
      • Arctic Wolf
      • AvertITD
      • Braintree
      • CallMiner
      • CambriLearn
      • CYBER1 Solutions
      • Digicloud Africa
      • Digimune
      • Domains.co.za
      • ESET
      • Euphoria Telecom
      • Incredible Business
      • iONLINE
      • Iris Network Systems
      • LSD Open
      • NEC XON
      • Network Platforms
      • Next DLP
      • Ovations
      • Paracon
      • Paratus
      • Q-KON
      • SevenC
      • SkyWire
      • Solid8 Technologies
      • Telit Cinterion
      • Tenable
      • Vertiv
      • Videri Digital
      • Wipro
      • Workday
    • Sections
      • AI and machine learning
      • Banking
      • Broadcasting and Media
      • Cloud services
      • Contact centres and CX
      • Cryptocurrencies
      • Education and skills
      • Electronics and hardware
      • Energy and sustainability
      • Enterprise software
      • Fintech
      • Information security
      • Internet and connectivity
      • Internet of Things
      • Investment
      • IT services
      • Lifestyle
      • Motoring
      • Public sector
      • Retail and e-commerce
      • Science
      • SMEs and start-ups
      • Social media
      • Talent and leadership
      • Telecoms
    • Events
    • Advertise
    TechCentralTechCentral
    Home » News » South Africa’s vaccine holdup piles the pressure on Ramaphosa

    South Africa’s vaccine holdup piles the pressure on Ramaphosa

    By Agency Staff21 January 2021
    Twitter LinkedIn Facebook WhatsApp Email Telegram Copy Link
    News Alerts
    WhatsApp
    President Cyril Ramaphosa. Image c/o GCIS

    Government, lauded for its swift lockdown in March to curb the spread of the coronavirus, is now being pilloried for being slow off the mark to secure vaccines.

    While developing nation peers such as Indonesia and Argentina are among more than 50 already administering shots, South Africa’s inoculation programme has yet to get off the ground. In December, it pinned down sufficient doses to cover just 10% of the population from Covax, a facility that aims to distribute vaccines equitably around the world. But those are only due to start arriving next month and the authorities have been scrambling to source additional supplies.

    The haphazard procurement process has angered South Africa’s top medical scientists and frustrated labour unions, business groups and opposition parties, who say the country doesn’t have time to lose. South Africa has confirmed 1.36 million infections so far, the most in Africa, and more than 38 000 deaths. Hospitals can barely cope with a resurgence in cases.

    This has been nothing short of criminal negligence. If this doesn’t get fixed it could destroy Cyril’s legacy or even his chances of a second term

    “It was poor planning on the part of the government,” said Shabir Madhi, a professor of vaccinnology and lead researcher for the South African arm of the AstraZeneca and University of Oxford vaccine trial. “They failed the country.”

    President Cyril Ramaphosa and health minister Zweli Mkhize have been shuttling between interviews to defend their approach. Their explanations, and those of other officials, range from not having the money to pay for shots upfront to proposed contracts breaching legislative and transparency requirements.

    Criticism

    Much of the criticism is directed at the Ministerial Advisory Committee on Vaccines and its chairman, Barry Schoub. Shortly after the panel was appointed in September, Schoub recommended that the country eschew direct talks with pharmaceutical companies and get shots from Covax instead. The government followed his advice and agreed to buy half the doses it was entitled to from the facility.

    Four months on, few suppliers can deliver at short notice, with a number of nations having prepaid to secure early access. Several companies that are still taking orders are charging less than the prices available from Covax, which enables rich and middle-income nations to subsidise poor ones.

    Schoub, Ramaphosa and Mkhize argued South Africa risked losing money if it entered bilateral agreements to secure vaccines that proved ineffective. Madhi said the deposits would be returned if the shots failed. Schoub didn’t respond to calls and messages seeking comment.

    Image: Daniel Schludi

    Ramaphosa this month announced a deal with the Serum Institute of India that will enable 750 000 health workers to get the AstraZeneca vaccines by the end of February. An additional 20 million courses, including the Covax allocation, have been secured from Pfizer, Johnson & Johnson and other suppliers, according to the president. He insists that preparations to vaccinate two-thirds of the population of 60 million by year-end began months ago.

    “We are going to be getting vaccines in the numbers we need,” he said at a 19 January briefing, where he announced the formation of an interministerial committee to oversee the inoculations. “It will be a game changer as far as dealing with the pandemic is concerned.”

    The 1.8 million-member Cosatu trade union federation, a key ally of the ANC, isn’t buying the government’s reassurances. “We read them the riot act. This has been nothing short of criminal negligence,” said Matthew Parks, Cosatu’s parliamentary coordinator. “If this doesn’t get fixed it could destroy Cyril’s legacy or even his chances of a second term.”

    The public has a right to know why, after six months, not one single bilateral agreement was signed…

    A failure to bring the pandemic under control could also erode support for the ANC in municipal elections due to take place later this year, and may enable Ramaphosa’s detractors within the party to question his credibility.

    A charity had to pay the Covax deposit after government missed a self-imposed deadline. Business organisations were only approached for help in early January. Medical insurers have agreed to pay for vaccines to cover their members and an equal number of others who don’t have cover.

    John Steenhuisen, the leader of the Democratic Alliance, said he’d been reliably informed that talks with reputable vaccine manufacturers only started this year.

    Alarm bells

    “The public has a right to know why, after six months of claimed negotiations, not one single bilateral agreement was signed and not a single dose secured for South Africa in 2020,” he told reporters this week.

    Leading scientists were the first to raise the alarm in a 2 January editorial in several South African publications, calling on Ramaphosa to fire health department officials who oversaw vaccine procurement. They included Glenda Gray, the president of the South African Medical Research Council, and other scientists who were removed without explanation from Mkhize’s advisory council in September.

    Schoub told the BBC that the scientists who penned the editorial “might have another agenda, which has caused them to go on a rampage” but didn’t say what the agenda might be.

    A vaccination campaign covering 67% of the population will cost about R20-billion, of which about 30% would be covered by medical insurers, according to Mkhize. That compares to a R389-billion loss in economic output in 2020, a 7 January paper by South African scientists asserted.

    Critics also say South Africa squandered the advantage of hosting as many as four Covid-19 vaccine trials — the only country in Africa to do so — as well as having Johnson & Johnson agree to use a South African factory that has the capacity to produce 300 million doses a year. All that should have helped secure deals, they said.

    Instead, South Africa may face months more of lockdowns, further resurgences and increasing isolation as other countries race ahead with inoculations. “They are simply going to close their borders to our goods and people,” said Parks. “Everybody is losing far more by not sorting this out.”  — Reported by Antony Sguazzin and Pauline Bax, (c) 2021 Bloomberg LP



    AstraZeneca Cyril Ramaphosa Glenda Gray Shabir Madhi top Zweli Mkhize
    Subscribe to TechCentral Subscribe to TechCentral
    Share. Facebook Twitter LinkedIn WhatsApp Telegram Email Copy Link
    Previous ArticleDeparting US FCC chair warns of threats to telecoms from China
    Next Article Bitcoin slumps 10% as pullback from record continues

    Related Posts

    Still in play: Ramaphosa banks on talks to ease US tariff blow

    8 July 2025

    Ramaphosa blasts Trump over threatened Brics tariffs

    8 July 2025

    Internet industry backs Solly Malatsi’s BEE reform plan

    3 July 2025
    Company News

    NEC XON welcomes HPE acquisition of Juniper Networks

    11 July 2025

    AI in project management: a new era of efficiency and transformation

    10 July 2025

    Samsung unfolds the future with thinnest, lightest Galaxy Z Fold yet

    9 July 2025
    Opinion

    In defence of equity alternatives for BEE

    30 June 2025

    E-commerce in ICT distribution: enabler or disruptor?

    30 June 2025

    South Africa pioneered drone laws a decade ago – now it must catch up

    17 June 2025

    Subscribe to Updates

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    © 2009 - 2025 NewsCentral Media

    Type above and press Enter to search. Press Esc to cancel.